EndObetes

New York, United States Founded: 2015 • Age: 11 yrs
Surgical access tool for obesity and diabetes treatment is developed.
Request Access

About EndObetes

EndObetes is a company based in New York (United States) founded in 2015 by Marc Bessler.. EndObetes offers products and services including Endoscopic Devices. EndObetes operates in a competitive market with competitors including Olympus, Fractyl, GI Windows, SurgiQuest and Eximis Surgical, among others.

  • Headquarter New York, United States
  • Founders Marc Bessler
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
Operational Areas
Healthcare → Healthcare Products & Supplies
Healthcare → Healthcare Products & Supplies
Healthcare → Medical Devices & Diagnostics
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
    $250.59 K (USD), Grant

    Jul 07, 2020

  • Investors
    HHS

    & 2 more

  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of EndObetes

EndObetes offers a comprehensive portfolio of products and services, including Endoscopic Devices. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Non-surgical devices for obesity and diabetes management through GI tract fixation.

Funding Insights of EndObetes

  • Total Funding
  • Total Rounds 3
  • Last Round Grant — $250,585
  • First Round
  • Investors Count 3
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2020 Amount Grant - EndObetes Valuation

investors

HHS
Jul, 2019 Amount Seed - EndObetes Valuation Biotechnology Innovation Organization
Jun, 2019 Amount Seed - EndObetes Valuation MedTech Innovator
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in EndObetes

EndObetes has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, Biotechnology Innovation Organization and MedTech Innovator. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Acceleration of medical device, digital health, and diagnostic companies is facilitated worldwide.
Founded Year Domain Location
Consulting in business development and communication is provided for biopharma.
Founded Year Domain Location
Public health and human services are overseen by HHS.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by EndObetes

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - EndObetes

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Endobetes Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of EndObetes

EndObetes operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Olympus, Fractyl, GI Windows, SurgiQuest and Eximis Surgical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Manufacturer of imaging and surgical products
domain founded_year HQ Location
Endoscopic procedures for type-2 diabetes treatment are developed.
domain founded_year HQ Location
Nonsurgical endoscopic devices for GI tract anastomoses are developed.
domain founded_year HQ Location
Products for minimally invasive surgery are developed and supplied.
domain founded_year HQ Location
Minimal invasive specimen removal tools
domain founded_year HQ Location
Minimally invasive systems for laparoscopic surgery are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Endobetes

Frequently Asked Questions about EndObetes

When was EndObetes founded?

EndObetes was founded in 2015 and raised its 1st funding round 4 years after it was founded.

Where is EndObetes located?

EndObetes is headquartered in New York, United States. It is registered at New York, New York, United States.

What does EndObetes do?

EndObetes was founded in 2015 in New York, United States, within the medical device sector focused on gastrointestinal interventions. A surgical access tool has been created to address obesity and diabetes through endoscopic delivery. The device is positioned in the GI tract to route undiluted food directly to the small intestine, replicating gastric bypass effects. Operations center on tool development and potential clinical applications in bariatric care.

Who are the top competitors of EndObetes?

EndObetes's top competitors include Olympus, Fractyl and GI Windows.

What products or services does EndObetes offer?

EndObetes offers Endoscopic Devices.

Who are EndObetes's investors?

EndObetes has 3 investors. Key investors include HHS, Biotechnology Innovation Organization, and MedTech Innovator.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available